OTC Pain Relief & Analgesics
•12 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (12)
%
| Company | Market Cap | Price |
|---|---|---|
|
OTC pain relief products are a core product category in CVS retail.
|
$98.55B |
$77.90
-0.33%
|
|
Offers over-the-counter pain relief/analgesics under its brands.
|
$41.10B |
$9.00
-0.22%
|
|
Tylenol and other OTC analgesics are core self-care offerings that Kenvue directly manufactures and sells.
|
$31.52B |
$16.18
-1.49%
|
|
Over-the-counter pain relief and analgesics form part of the consumer healthcare exposure.
|
$11.96B |
$14.34
+1.63%
|
|
Walgreens sells OTC pain relief and analgesics as a major consumer health product category.
|
$10.36B |
$11.98
|
|
OTC pain relief products are a product category Albertsons offers in-store.
|
$9.86B |
$17.12
-1.10%
|
|
PBH markets OTC analgesics (e.g., Goody's) as part of its pain relief portfolio.
|
$3.01B |
$61.00
-2.80%
|
|
OTC pain relief products are a core self-care category for Perrigo.
|
$2.92B |
$21.25
-1.67%
|
|
ZTlido (lidocaine topical system) is a topical analgesic product developed and sold by Scilex, fitting the pain-relief product category.
|
$103.79M |
$14.93
-15.27%
|
|
OTC Pain Relief & Analgesics private-label product line.
|
$37.68M |
$4.38
-8.68%
|
|
Halo-Lido is a topical OTC hemorrhoids treatment, a direct consumer medical product offering.
|
$12.66M |
$1.23
-6.11%
|
|
The pharmaceutical/OTC verticals imply involvement in OTC analgesics products, a visible OTC category.
|
$10.55M |
$1.30
-2.99%
|
Loading industry metrics...
Loading comparison data...
